Alec Maynard
Impact in
- Oncology top 10%
- COVID-19 and healthcare impacts
- Cancer Immunotherapy and Biomarkers
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
- Oncology 6
- COVID-19 and healthcare impacts 5
- Colorectal Cancer Screening and Detection 1
-
- COVID-19 Clinical Research Studies 3
- Co-authors
- Gwilym James Webb (1 shared paper)John M. Hebden (1 shared paper)Elizabeth J. Williams (1 shared paper)Sharon Docherty (1 shared paper)Jonathon A Snook (1 shared paper)Thomas Chapman (1 shared paper)Antony J. Ellis (1 shared paper)Brian S. F. Shine (1 shared paper)
- Journals
- JAMA Network Open (1 paper)The Lancet Oncology (1 paper)ESMO Open (1 paper)Cancers (1 paper)JCO Clinical Cancer Informatics (1 paper)
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
Alec Maynard
6 papers receiving 508 citations
Alec Maynard's Hit Papers
Peers
Comparison fields: 5 of 44
- Oncology 330
- Infectious Diseases 226
- Health 14
- Hematology 14
- Modeling and Simulation 5
Countries citing papers authored by Alec Maynard
This map shows the geographic impact of Alec Maynard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alec Maynard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alec Maynard more than expected).
Fields of papers citing papers by Alec Maynard
This network shows the impact of papers produced by Alec Maynard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alec Maynard. The network helps show where Alec Maynard may publish in the future.
Co-authors
The 8 scholars most cited alongside Alec Maynard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study Hit paper breakdown → | 2020 | 450 |
| 2 | 2022 | 45 | |
| 3 | 2021 | 12 | |
| 4 | 2022 | 6 | |
| 5 | 2021 | 3 | |
| 6 | 2022 | 2 |
About Alec Maynard
Alec Maynard is a scholar working on Oncology, Infectious Diseases, Gastroenterology, Surgery and Nuclear Energy and Engineering, having authored 6 papers that have together received 518 indexed citations. Recurring topics across this work include COVID-19 and healthcare impacts (5 papers), COVID-19 Clinical Research Studies (3 papers), Gastrointestinal Bleeding Diagnosis and Treatment (1 paper), Colorectal Cancer Screening and Detection (1 paper) and Helicobacter pylori-related gastroenterology studies (1 paper). The work is most often cited by research in Oncology (330 citations), Infectious Diseases (226 citations), Health (14 citations), Hematology (14 citations) and Modeling and Simulation (5 citations). Alec Maynard has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Gwilym James Webb, John M. Hebden, Elizabeth J. Williams, Sharon Docherty, Jonathon A Snook, Thomas Chapman, Antony J. Ellis and Brian S. F. Shine. Their work appears in journals such as JAMA Network Open, The Lancet Oncology, ESMO Open, Cancers and JCO Clinical Cancer Informatics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.